Healthcare

Best Performing Equity Today

Pharnext

150.00%

Healthcare Insights

insight

Healthcare

Incannex Healthcare: Is life better on Nasdaq?

insight

Healthcare

An update on OpGen: Deals, expansion and revenues

insight

Healthcare

Volition: Views from the sharp end

Incannex mother and child

insight

Healthcare

Incannex Healthcare: Data opens path to treat anxiety

insight

Healthcare

February 2023 Edition of Edison Healthcare Insight

Analyst of the week

Soo Romanoff

Soo Romanoff

Managing Director - Head of Content, Healthcare

Read latest

Equities

Actinogen Medical (ACW)

Latest price

AUD0.03

0.01 (50.00)
As at 21/09/2023
Market capitalisation
AUD48m
View equity

AFT Pharmaceuticals (AFT)

Latest price

NZD3.48

0.13 (3.88)
As at 21/09/2023
Market capitalisation
NZD351m
View equity

Basilea Pharmaceutica (BSLN)

Latest price

CHF43.05

−0.45 (−1.03)
As at 21/09/2023
Market capitalisation
CHF572m
View equity

Biodexa Pharmaceuticals (BDRX)

Latest price

USD4.94

−0.99 (−16.69)
As at 21/09/2023
Market capitalisation
USD3m
View equity

Cantargia (CANTA)

Latest price

SEK4.24

−0.14 (−3.20)
As at 21/09/2023
Market capitalisation
SEK665m
View equity

Chosa (CHOSA)

Latest price

SEK1.30

−0.23 (−15.03)
As at 21/09/2023
Market capitalisation
SEK56m
View equity

Update

Healthcare

Chosa Oncology — Making headway in precision oncology

Update

Healthcare

RhoVac — On the home straight

Outlook

Healthcare

RhoVac — Phase IIb BRaVac study results in H122

Creo Medical (CREO)

Latest price

GBP0.32

−0.50 (−1.54)
As at 21/09/2023
Market capitalisation
GBP117m
View equity

e-therapeutics (ETX)

Latest price

GBP0.13

−0.22 (−1.61)
As at 21/09/2023
Market capitalisation
GBP80m
View equity

Immix Biopharma (IMMX)

Latest price

USD3.45

0.46 (15.38)
As at 21/09/2023
Market capitalisation
USD54m
View equity

Incannex Healthcare (IXHL)

Latest price

USD1.11

−0.09 (−7.50)
As at 21/09/2023
Market capitalisation
USD80m
View equity

IRLAB Therapeutics (IRLABA)

Latest price

SEK6.60

0.02 (0.30)
As at 21/09/2023
Market capitalisation
SEK358m
View equity

Kinarus Therapeutics (KNRS)

Latest price

CHF0.01

0.00 (−16.67)
As at 21/09/2023
Market capitalisation
CHF6m
View equity

Mendus (IMMU)

Latest price

SEK0.45

0.01 (2.27)
As at 21/09/2023
Market capitalisation
SEK382m
View equity

MindMed (MNMD)

Latest price

USD3.70

−0.24 (−6.09)
As at 21/09/2023
Market capitalisation
USD160m

Molecure (MOC)

Latest price

PLN19.18

−0.10 (−0.52)
As at 21/09/2023
Market capitalisation
PLN275m
View equity

Newron Pharmaceuticals (NWRN)

Latest price

CHF5.44

0.02 (0.37)
As at 21/09/2023
Market capitalisation
CHF98m
View equity

Curated by Edison

The Next Step for AI in Biology Is to Predict How Proteins Behave in the Body - Thumbnail image

singularityhub.com

The Next Step for AI in Biology Is to Predict How Proteins Behave in the Body

Healthcare

A new protein atlas can help turn static AI predictions of protein shapes into more fluid predictions of how proteins behave in the body.

Read article
The Cost of Sequencing a Human Genome - Thumbnail image

www.genome.gov

The Cost of Sequencing a Human Genome

Healthcare

Estimated cost of sequencing the human genome over time since the Human Genome Project.

Read article
J.P. Morgan Launches New Life Sciences Private Capital Team Targeting Investments in Innovative Healthcare Companies - Thumbnail image

www.prnewswire.com

J.P. Morgan Launches New Life Sciences Private Capital Team Targeting Investments in Innovative Healthcare Companies

Healthcare

/PRNewswire/ -- J.P. Morgan Asset Management today announced the launch of a new life sciences private equity team, Life Sciences Private Capital. The new team...

Read article
Leveraging nanotechnology to transform the disinfection industry - Thumbnail image

insights.omnia-health.com

Leveraging nanotechnology to transform the disinfection industry

Healthcare

Co-founders of Kismet Technologies, Christina Drake and Shari Costantini, discuss how NanoRad, one of their flagship products, uses targeted application to kill a wide range of bacteria and viruses.

Read article
2022 Healthcare Provider IT Report: Post-Pandemic Investment Priorities - Thumbnail image

www.bain.com

2022 Healthcare Provider IT Report: Post-Pandemic Investment Priorities

Healthcare

As healthcare providers enter a new period of disruption, their software investment priorities present opportunities for vendors and investors.

Read article

Thematics

thematic

Healthcare

ASCO 2023 key takeaways

thematic

Healthcare

Machine learning in drug development

cell DNA double helix

thematic

Healthcare

Cell and gene therapies

thematic

Healthcare

Drug delivery platforms

thematic

Healthcare

Neuroscience comeback

Subscribe to Edison

Get access to the very latest content matched to your personal investment style.

Sign up for free